Astraveus raises €16.5 million to advance cell and gene therapy manufacturing platform
Astraveus, the creator of modular, microfluidic cell foundries for cell and gene therapy (CGT) manufacturing, has raised €16.5 million in series seed financing.
Archives for June 29, 2023
EU recognition boosts Bimzelx’s profile as innovative interleukin-17 inhibitor therapy
UCB recently announced the European Commission approval for Bimzelx (bimekizumab), its humanized monoclonal IgG1 antibody.
Microbiome transplant to treat vaginal tract dysbiosis clears phase 1 milestone
A microbiome therapeutic developed by the Danish biotech company Freya Biosciences has achieved promising topline results in a phase 1 trial in women with asymptomatic vaginal tract dysbiosis.